000045910 000__ 00855cam\a22003495i\4500
000045910 001__ 45910
000045910 003__ SzGeWIPO
000045910 005__ 20240708150219.0
000045910 006__ m\\\\eo\\d\\\\\\\\
000045910 007__ cr bn |||m|||a
000045910 008__ 220425s2022\\\\enk\\\\\o\\\\\000\0\eng\d
000045910 035__ $$a(OCoLC)1335038590
000045910 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000045910 041__ $$aeng
000045910 24500 $$aPharmaceutical Invention Claiming a Specific Particle Size Distribution Deemed Non-Obvious.
000045910 264_1 $$a[Oxford, England] :$$bOxford University Press (OUP),$$c2022
000045910 300__ $$a1 online resource (pages 447-455)
000045910 336__ $$atext$$2rdacontent
000045910 337__ $$acomputer$$2rdamedia
000045910 338__ $$aonline resource$$bcr$$2rdacarrier
000045910 4901_ $$aGRUR International,$$x2632-8550 ;$$v71, 5, 2022
000045910 542__ $$fhttps://academic.oup.com/grurint/article/71/5/447/6524590
000045910 588__ $$aCrossref
000045910 590__ $$aPublished online: 08-Feb-22
000045910 650_0 $$aIntellectual property.
000045910 650_4 $$aPharmaceuticals.
000045910 7731_ $$tGRUR International$$wGRUR
000045910 830_0 $$aGRUR International ;$$v71, 5, 2022.
000045910 85641 $$uhttps://academic.oup.com/grurint/article/71/5/447/6524590$$yonline version
000045910 904__ $$aJournal article
000045910 980__ $$aGRUR